Skybiotech Healthcare LtdBSE: SKYBIOTECH

Closure of Trading Window

· Issued by Skybiotech Healthcare Ltd via BSE India

Filed with BSE · · 1 page · English

Summary by 6ix AI

This decision is in compliance with the SEBI regulations regarding insider trading and the company's internal code of conduct. All designated persons and their immediate relatives are advised against trading in the company's shares during this period.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/closure-of-trading-window-163

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and as per Company’s Code of Conduct for the Prevention of Insider Trading and Code of Corporate Disclosure Practices, the Trading Window shall remain closed for trading in Securities of the Company w.e.f. 1st October, 2026 till the completion of 48 hours after declaration of the unaudited Financial Results for the Quarter ende

Skybiotech Healthcare Ltd on 6ix

Earlier from Skybiotech Healthcare

Later from Skybiotech Healthcare

All Skybiotech Healthcare news releases